Rice, S. A.
Mikes, M.
Bibus, D.
Berdyshev, E.
Reisz, J. A.
Gehrke, S.
Bronova, I.
D’Alessandro, A.
Drew, K. L.
Funding for this research was provided by:
National Institute of General Medical Sciences of the National Institutes of Health (2P20GM103395, P20GM130443)
NIH Common Fund (TL4GM118992)
NSF (1258179)
Article History
Received: 11 July 2020
Accepted: 20 October 2020
First Online: 14 January 2021
Competing interests
: SR, MM, EB, IB, AD, SG, JR declare no conflict of interest. KLD has a financial interest in Be Cool Pharmaceutics and DB has a financial interest in Lipid Technologies, LLC.